AIFinancial Timesabout 1 hour ago
Schrödinger and Bristol Myers Squibb Partner on AI Drug Discovery
1 min read
Schrödinger announced a strategic collaboration and software agreement with Bristol Myers Squibb to deploy its AI co-scientist Bunsen for agentic drug discovery. The partnership centers on using Schrödinger's platform to advance Bristol Myers Squibb's research efforts.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
